ELV · ISSUER CIK 1156039
Elevance Health, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Elevance Health, Inc. insiders reported $0.00 of open-market purchases and $4.7M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$4.7MInsider selling
−$4.7MNet open-market
Oct 23, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 202616:30 | Oct 22, 2026 | ELV | EVP & CFO | S · Sell | $440.13 | −10,584 | 19,919 | -35% | −$4.7M | ||
| Oct 6, 202616:02 | Oct 2, 2026 | ELV | EVP & CFO | F · Tax | $386.43 | −4,161 | 27,876 | -13% | $1.6M | ||
| Oct 6, 202616:02 | Oct 2, 2026 | ELV | EVP & CFO | A · Grant | — | +2,627 | 30,503 | +9% | — | ||
| Sep 4, 202616:06 | Sep 3, 2026from Sep 2, 2026 | ELV | EVP & Chief Legal Officer | F · Tax | $412.37 | −349 | 7,230 | -5% | $144K | ||
| Sep 4, 202616:05 | Sep 2, 2026 | ELV | EVP & Chief HR Officer | F · Tax | $405.84 | −144 | 6,530 | -2% | $58K |